Judge Axes IP Suit Over Xifaxan, Ruling The Drug Is Prior Art | McDermott

McDermott Will & Schulte, a global law firm

COVERAGE

Judge Axes IP Suit Over Xifaxan, Ruling The Drug Is Prior Art

August 17, 2022

Read time: 2 min

Thomas Steindler and April Weisbruch are featured in Law360 for representing Salix, Bausch Health Cos. and Alfasigma in an IP dispute.

Thomas P. Steindler

Partner

Washington, DC

You may also like